retatrutide weight loss results clinical trial stage New Phase 3 data just dropped 👀 Eli Lilly's reported average Retatrutide Phase 3: TRIUMPH Program

Modern GLP-1/GIP therapies are designed to work with your bodys natural metabolic signals, helping regulate appetite, improve insulin sensitivity, and support sustainable fat loss without the crash-and-burn cycle of traditional dieting

It is important to emphasize that the risk of eye problems appears primarily concentrated in patients with pre-existing diabetic retinopathy who experience rapid glycemic improvement

Hepatic and Metabolic Benefits A MAFLD/MASLD (metabolic dysfunction-associated steatotic liver disease) sub-study of the Phase 2 obesity trial reported that over 85% of participants on the highest retatrutide doses achieved more than 30% reduction in liver fat content measured by MRI, with many reaching complete resolution of steatosis

Apply sunscreen